Collectively, the expression of CARM1 was elevated in various cancers including breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), lymphoid neoplasm diffuse large B cell lymphoma (DLBC), colon adenocarcinoma (COAD), glioblastoma multiforme (GBM), esophageal carcinoma (ESCA), LGG (brain lower-grade glioma), HNSC, LUSC, OV (ovarian serous cystadenocarcinoma), rectum adenocarcinoma (READ), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), pancreatic adenocarcinoma (PAAD), and thymoma (THYM), as shown in Figure 2(a). This evidence concerns the gene CARM1 and glioblastoma.